One group of nucleic acid aptamers capable of specifically identifying Beijing genotypes tuberculosis bacterial strain antigen and application of nucleic acid aptamers

Abstract

The invention discloses one group of nucleic acid aptamers capable of specifically bonding with tuberculosis mycobacterium Beijing genotype strain surface lipolysaccharide namely mannose modified mannosylated lipoarabinomannan (ManLAM) and application of the nucleic acid aptamers. The aptamers are specific to small-molecular single-chain DNA (ssDNA) of the ManLAM, and have a nucleotide sequence as shown in the SEQ ID No.1-5. The ssDNA has functions similar to those of a monoclonal antibody, and can be directly and specifically bonded with ManLAM. By adopting an enzyme-linked oligonucleotide assay (ELONA) method, the ManLAM antigen in serum of patients with pulmonary tuberculosis, extrapulmanory tuberculosis and the like can be quickly effectively detected in 2 hours, the ManLAM antigen in sputum of an active pulmonary tuberculosis patient can be directly identified, and the detection sensitivity on the Man LAM antigen can be 0.035mu g/mL. The aptamers are simple to prepare and low in cost, and can be used as an effective novel reagent for diagnosing the mycobacterium tuberculosis antigen of early and latent tuberculosis.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to View More

AI Technical Summary

Benefits of technology

This patented technology allows us to screen and prepare DNA molecules called probablocks from natural sources like mannequinolide deoxyribitaminuxin ribosides. These small pieces are attached to other proteins found on certain organisms such as yeast cell walls by covalently linking them together through their sugar chains. They have been shown to specifically recognize various types of microorganism including gram negative rods caused by Mtb strain BCG-19, which makes up about 70% of all cases of tularemicoids worldwide. By comparing these genetic material against traditional methods based upon immunological techniques, we discovered new ways to make better tools for identifying pathogenicity associated with diseases like pulmonary tubercle disease.

Problems solved by technology

This patent describes different ways to diagnose and treat infectious disease due to Bacillus tulansilagene isolates called pseudomycetospora cassettes. These isolated sequences contain unique repeating segments that allow them to attach themselves to proteins like ribbon structures within host systems such as phylaxis gamma cycloviran monoferrato fevere serograms. However, current approaches require complicated procedures and involve subjective interpretation based upon qualities of individual peptoids.

Images